Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, April 29, 2020

Responsiveness and Predictive Validity of the Hierarchical Balance Short Forms in People With Stroke

Didn't read; prediction crap, useless.

Don't we have any stroke leaders who recognize the fucking stupidity of stroke recovery predictors and stop this research crapola?  THEY ARE TOTALLY FUCKING USELESS TO SURVIVORS.  Redirect it to actual recovery research creating protocols?

Responsiveness and Predictive Validity of the Hierarchical Balance Short Forms in People With Stroke

Hsueh and Ching-Lin HsiehWan-Hui Yu, Kuan-Lin Chen, Yeh-Tai Chou, I-Ping
PHYS THER. 20132013; 93:798-808.
Originally published online February 7,2013
doi: 10.2522/ptj.20120259
 Background.
 The lack of knowledge about the responsiveness and predictive validity of a set of Hierarchical Balance Short Forms (the HBSF) in people with stroke limits the utility of the HBSF in both clinical and research settings.
Objective.
 The purpose of this study was to investigate the responsiveness and predictive validity of the HBSF in people receiving inpatient rehabilitation after stroke.
Design.
 A prospective cohort study was conducted.
Methods.
 Sixty-six participants completed both the 6-item HBSF and the 12-itemPostural Assessment Scale for Stroke (PASS) after admission to the rehabilitation ward and before hospital discharge. The standardized effect size (ES) and the standardized response mean (SRM) were used to investigate the internal responsiveness of theHBSF and the PASS. Changes in the Barthel Index and the mobility subscale of the Stroke Rehabilitation Assessment of Movement were used as the external criteria for examining external responsiveness. Moreover, the admission scores on the HBSF and the PASS and the discharge scores on the Barthel Index and mobility subscale of the Stroke Rehabilitation Assessment of Movement were analyzed to investigate the predictive validity of the 2 balance measures.
Results.
 The internal responsiveness of the HBSF was high (ES>0.9, SRM>1.6).The SRM of the HBSF was significantly larger than that of the PASS, whereas the ESof the HBSF was not significantly larger than that of the PASS. The external responsiveness and predictive validity of the HBSF were sufficient and similar to those of the PASS (external responsiveness:
 r ≥ .35; predictive validity: r ≥ .67).
Limitations.
 The convenience sampling of people receiving inpatient rehabilitation after stroke may limit the generalization of the results.
Conclusions.
 The HBSF has sufficient responsiveness and predictive validity in people receiving inpatient rehabilitation after stroke and is thus recommended for both clinicians and researchers.

No comments:

Post a Comment